X

Immunic AG & Vital Therapies join forces to start a biopharma company

Vital Therapies, Inc., a biotechnology company based in California, has reportedly entered into a definitive…

Ojaswita Kutepatil

Paragon, MGI team up to distribute CleanPlex® NGS Panels worldwide

Paragon Genomics, Inc., has recently announced a worldwide partnership with the subsidiary of BGI Group,…

Ojaswita Kutepatil

Merck to license NGM313 for treating Type 2 Diabetes and NASH

In a recent turn of events, Merck & NGM Biopharmaceuticals Inc. jointly declared that Merck…

Ojaswita Kutepatil

Merus, Betta Pharma team up to develop and market MCLA-129 in China

Biotech firm Merus N.V. has announced that the company has agreed to provide an exclusive…

Ojaswita Kutepatil

Cybrexa announces CBX-11 as clinical candidate to treat solid tumors

Biotechnology firm Cybrexa Therapeutics, that was developing a new class of cancer therapeutics via its…

Ojaswita Kutepatil

UC develops new brain pacemaker to help treat epilepsy, Parkinson’s

The breakthrough will help prevent incapacitating tremors or seizures in patients with diverse neurological conditions.…

Ojaswita Kutepatil

Cabinet okays National Commission for Indian Systems of Medicine Bill

The draft National Commission for Indian Systems of Medicine Bill, 2018, that was formed to…

Ojaswita Kutepatil

Perlara, Rambam Medical Center tie up for kidney disease PerlQuest

Perlara, the U.S. based biotech public benefit corporation that is dedicated to discovering cures for rare diseases,…

Shikha Sinha

OmniComm, Hitachi join forces to provide eClinical Solutions in Japan

Reports confirm that the leading provider of clinical data management technology, OmniComm Systems, Inc., has…

Ojaswita Kutepatil